Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01782781Phase 3Completed
Phase 3, randomised, double-blind trial of ropivacaine, ketorolac and epinephrine in postoperative pain (2 arms), sponsored by University of Gothenburg. Primary endpoint: Total morphine consumption at 24 hours. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01782781.